Mono most commonly affects those between the ages of 15 to 24 years in the developed world, while in the developing world, people are more often infected in childhood.

About 25% of adults worldwide have cardiometabolic syndrome, a combination of metabolic dysfunctions that is challenging to treat and burdensome to healthcare systems.

This toxicity is the most common cause of acute liver failure and the second most common cause of liver failure requiring transplantation.

Five FDA-approved treatments target the symptoms of this neurologic disease, with the primary goal of improving patients’ quality of life.

Hemodialysis and peritoneal dialysis remove waste and excess water from the blood to enhance a kidney patient’s quality of life.

Highly contagious and environmentally stable, strains of this viral pathogen are now the leading cause of diarrheal diseases across all age groups.

Despite evidence that lacking this fat-soluble secosteroid might contribute to CVD, more clinical studies are needed to identify the cause and effect.

Effective treatment approaches depend on the type and severity of the disease.

Hoarding is a behavior that can vary from mild to life-threatening. Hoarding disorder can be treated with pharmacotherapy, psychotherapy, or both.